These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28616428)

  • 41. Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats.
    Ashraf GM; Alghamdi BS; Alshehri FS; Alam MZ; Tayeb HO; Tarazi FI
    Front Pharmacol; 2021; 12():578716. PubMed ID: 33953666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conventional and Alternative Mesenchymal Stem Cell Therapies for the Treatment of Diabetes.
    Rifai L; Saleh FA
    Adv Exp Med Biol; 2021; 1312():97-106. PubMed ID: 33385177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of vagus nerve stimulation strategies on glycemia and pancreatic secretions.
    Payne SC; Ward G; MacIsaac RJ; Hyakumura T; Fallon JB; Villalobos J
    Physiol Rep; 2020 Jun; 8(11):e14479. PubMed ID: 32512650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood Glucose Control and Opportunities for Clinical Pharmacists in Infectious Diseases Ward.
    Shabani M; Rashedi M; Razzazzadeh S; Saffaei A; Sahraei Z
    J Res Pharm Pract; 2019; 8(4):202-207. PubMed ID: 31956633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of Diabetes in Patients Undergoing Bariatric Surgery.
    Mulla CM; Baloch HM; Hafida S
    Curr Diab Rep; 2019 Nov; 19(11):112. PubMed ID: 31686263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Similarities and Distinctions in the Effects of Metformin and Carbon Monoxide in Immunometabolism.
    Park J; Joe Y; Ryter SW; Surh YJ; Chung HT
    Mol Cells; 2019 Apr; 42(4):292-300. PubMed ID: 31091555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variability in the therapeutic response of Metformin treatment in patients with type 2 diabetes mellitus.
    Rashid M; Shahzad M; Mahmood S; Khan K
    Pak J Med Sci; 2019; 35(1):71-76. PubMed ID: 30881399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CYC27 Synthetic Derivative of Bromophenol from Red Alga
    Luo J; Jiang B; Li C; Jia X; Shi D
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30641913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Galangin, a dietary flavonoid, ameliorates hyperglycaemia and lipid abnormalities in rats with streptozotocin-induced hyperglycaemia.
    Aloud AA; Chinnadurai V; Govindasamy C; Alsaif MA; Al-Numair KS
    Pharm Biol; 2018 Dec; 56(1):302-308. PubMed ID: 29952676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients.
    Siavash M; Tabbakhian M; Sabzghabaee AM; Razavi N
    J Res Pharm Pract; 2017; 6(2):73-76. PubMed ID: 28616428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
    Blonde L; Dailey GE; Jabbour SA; Reasner CA; Mills DJ
    Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of Diversity of Metformin Related Gastrointestinal Side Effects.
    Saluja M; Pareek KK; Swami YK
    J Assoc Physicians India; 2020 Aug; 68(8):36-38. PubMed ID: 32738838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients.
    Guo L; Guo X; Li Y; Hong X; Jiang X; Su Q; Zhao D; Wu X; Ji L
    Diabetes Metab Syndr; 2016; 10(3):137-42. PubMed ID: 26948203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study.
    Kumar KMP; Chawla M; Sanghvi A; Sastry NG; Kotla C; Phatak S; Choudhari S
    Int J Gen Med; 2019; 12():147-159. PubMed ID: 31040711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding and overcoming metformin gastrointestinal intolerance.
    Bonnet F; Scheen A
    Diabetes Obes Metab; 2017 Apr; 19(4):473-481. PubMed ID: 27987248
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.